Scientific program
The scientific program “Preparing for the future” will showcase the latest developments in clinical chemistry. We aim to cover state-of-the-art knowledge in a wide variety of fields of clinical chemistry bridging basic research and clinical application, and spanning from practical issues in daily routine to advanced data science. New technological developments as well as requirements to prepare for a future successful career in clinical chemistry will be covered. Our invited plenary speakers provide cutting edge updates with an in-depth focus on cardiometabolic disease, coagulation and neurodegenerative disease. We expect that our ambitious program will fulfill the needs of virtually everybody working in and around the exciting field of clinical chemistry.
Development and Improvements
For the XXXIX Nordic Congress in Clinical Chemistry, we are excited to present a new topic “Development and Improvements” as a complement to the scientific program. This topic fosters collaboration among professionals from various disciplines, including clinical chemists, laboratory technicians, biomedical scientists, researchers, and healthcare providers to shed light upon intriguing subjects.
Key features and components of the area include:
-
Advances in the area Artificial Intelligence (AI) and the future of laboratories.
-
Diversity and inclusion in laboratory professions and opportunities for career growth.
-
Evolving skill sets (task-shifting) and competencies required for careers in future laboratories.
-
Healthy and sustainable workplace-environments.
-
Examples and lessons learned from laboratories during times of crisis.
There is an immense anticipation for the XXXIX Nordic Congress in Clinical Chemistry and by addressing these topics, the congress can foster dialogue, collaboration, and knowledge sharing among stakeholders involved in shaping the future of laboratories. It can also promote innovation and resilience in laboratories to address a wide range of challenges, from scientific breakthroughs to crises like pandemics. Hope to see you in the beautiful city of Stockholm soon!
Program for download
-
Tuesday 17 September 2024
Aula Medica 09:00 Registration opens 11:00 Lunch opens (drop in) 12:30 Opening ceremony and Welcome 12:45 Plenary session on Cardiovascular disease: Lipid profile and cardiovascular disease
Chair: U Tietge (Sweden)
13:30 Break 13:45 The Lorentz Eldjarn Prize Competition for Best Publication
Prof. JP Berg, Managing Editor of SJCLI (Norway)
Prof. A Larsson (Sweden) Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients
Assoc prof. C Bødker Hviid (Denmark) Groundwork on Neurofilament Light Chain to facilitate clinical use and academic research
Prof. A Christensson (Sweden) Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities15:15 Coffee & Exhibition Aula Medica Sune Bergström Hall Ulf von Euler Hall 15:45 Session by NFKK: Recommendations from The Nordic preanalytical scientific working group
Chair: M Nybo (Denmark)
Prof. Dr. J Cadamuro (Austria) Progress in Europe on the preanalytical area
PhD G B B Kristensen (Norway) Recommendation on how to handle hemolysis indices
Assoc prof. M Nybo (Denmark) Nordic fasting recommendation – how to proceed?
Development & Improvement track
Clinical chemistry through the ages: milestones, discoveries and innovations
Chair: H Dahl (Sweden)
Assoc Prof. A Kallner (Sweden) Multae modicae gradus...Milestones in measuring biomarkers
Prof. K Pulkki (Finland) Milestones and co-operation in laboratory medicine during the last 100 years
Kidney function measurement – what is needed in clinical practice?
Chair: U Tietge (Sweden)
PhD MD P Delanaye (Belgium) How to estimate GFR in 2024?
Prof. M de Borst (The Netherlands) Kidney function: glomerular filtration rate and beyond
T Szili-Torok (The Netherlands) Oral abstract -Time to event prediction of new-onset diabetes after transplantation in kidney transplant recipients using machine learning
17:15 Poster reception and mingle in Aula Medica 17:45 - 18:00 Price ceremony for The Lorentz Eldjarn Prize Competition for Best Publication 19:30 End of program -
Wednesday 18 September
Aula Medica Sune Bergström Hall Ulf von Euler Hall 07:30 Educational session
Hot debate - Pros and cons of large-scale screening
PhD MD N Bark (Sweden)
MD S Johansson-Lennartdotter (Sweden)
Educational session
Dyslipidemia – selected case discussion
MD D Eklund (Sweden)
Educational session
Hematology – selected case discussion
08:15 Break 08:30 Nordic screening and testing programs
Chairs: L Franzson (Iceland) & P Bjellerup (Sweden)
Prof. S Y Kristinsson (Iceland) Screening for monoclonal gammopathy of undetermined significance: a nationwide randomized clinical trial
Prof. O Bratt (Sweden) Outcome of organised PSA testing in Sweden - Is there enough benefit?
Predicting the unpredictable? Novel developments to personalize healthcare
Chair: P Parini (Sweden)
S Chakraborty (Norway) Oral abstract - Reference intervals for serum Vitamin B12 and Active B12 in an adult population using an indirect approach
Erythrocyte disorders
Chair: S Beshara (Sweden)
Prof. A Iolascon (Italy) New insight in red cell membrane disorders: diagnosis and treatment
PhD MD O Klingenberg (Norway) - Hemoglobinopathies – a Norwegian perspective
MD T Lahtiharju (Finland) Oral abstract- Ferritin outperforms other biomarkers in predicting bone marrow iron stores in haematological patients10:00 Coffee & Exhibition 10:30 Tumor markers in plasma or serum
– where do we stand today?
Chair: M Hansson (Sweden)
Alcohol and drug testing - new substances and new analytical problems
Chair: G Eggersten (Sweden)
Transfer of PFAS from the mother and associated metabolic and neurodevelopmental changes in the child
Chair: I Hokstad (Norway)
11:00 Break Aula Medica 11:15 The Margareta Blombäck plenary session on Coagulation: Thrombotic Microangiopathies (TMA) - many diseases not so many tests- Special Focus om Preeclampsia
Chair: Prof. J Antovic (Sweden)
12:00 12:00-13:45 Lunch & Exhibition Aula Medica Sune Bergström Hall Company session organised by Snibe
New insights in autoantibody testing in diabetes
Prof. Mario Plebani, EFLM PresidentCompany session organised by Siemens Healthineers
Chronic Liver Disease, the Diagnostic Challenge13:00 12:00-13:45 Lunch & Exhibition Aula Medica Sune Bergström Hall Ulf von Euler Hall 13:45 Session by Institutet för biomedicinsk laboratorievetenskap
Chair: S Kronberg (Sweden) and M Quttineh (Sweden)
Biomed lab scientist M Quttineh (Sweden) Actionplan for the Future- the situation for biomedical laboratory scientists in Denmark, Finland, Norway, and Sweden
Development & Improvement track
Laboratory Medicine in times of crisis
Chair: M Lambert (Sweden)
RN, BSc, MA/MTh J Ruthman Gunnarsson (Sweden)Doctor Without Borders and our role in crisis
PhD, A Eriksson (Sweden) Global Disaster Medicine-Health needs and response
Thrombotic microangiopathies - many diseases not so many tests
Chair: J Antovic (Sweden)
Prof. J Antovic (Sweden) New approaches in the laboratory diagnosis of HUS/TTP
PhD MD M Farm (Sweden) Laboratory role in the diagnosis and follow up the treatment in HIT
MD A Kimiaei (Sweden) Implementing the ISTH guidelines for the diagnosis of lupus anticoagulant - our experience and lessons learned
15:15 Coffee & Exhibition 15:45 New targets, new opportunities? Cardiovascular biomarkers today and tomorrow
Chair: U Tietge (Sweden)
MD PhD D.O. Arnar (Iceland) Cardiac biomarkers, proteomics and genetics: a view towards the future
Prof. U Tietge (Sweden) Cardiovascular disease biomarkers today and tomorrow
A Havelka (Norway) Oral abstract - Development and diagnostic utility of immunoturbidimetric NT-proBNP assay based on antibodies targeting glycosylation-free regions of NT-proBNP
MD D Eklund (Sweden) Oral abstract - Impact of LDL-Cholesterol Formula Choice on Clinical Practice: Sampson and Martin-Hopkins versus Friedewald.Liver diseases - an expanding medical field
Chair: M Hansson (Sweden)
Dr. M van Berkel (Netherlands) EQuitABILIty study: towards harmonization of neonatal bilirubin
Adjunct Prof. H Hagström (Sweden) Diagnosis and prognosis of steatotic liver disease
Development & Improvement track
Healthy Workplaces, Healthy Workers: Tips and Tricks for Lab Pros
Chair: M Shafaati Lambert (Sweden)
RN. CCN. MSc. M Flodberg (Sweden) Wellness center – Employee health
Å Malmenklev (Sweden) Focus on the resilience for the staff of the hospital
17:15 End of day -
Thursday 19 September
Aula Medica Sune Bergström Hall Ulf von Euler Hall 07:30 Educational session
Inborn errors of metabolism – newborn screening
MScPharm L Franzson (Iceland)
Educational session
New aspects on Vitamin B12 and folate deficiency and the toxic effect of laughing gas
08:15 Break 08:30 AI - the future colleague in clinical chemistry
Chair: P Parini (Sweden)
Dr. G Menichetti Integrating Network Medicine and AI: Insights from the Foodome Project(USA)
MD T Lahtiharju (Finland) Oral abstract- Neural network models can replace manual work in serum protein electrophoresis interpretation
Assoc Prof. N Fyhrquist (Sweden) Transforming Healthcare: AI in Diagnostics and Patient Treatment
Session by the Swedish Association of Clinical Biochemists - Clinical importance of measurements of low levels of sex hormones
Chair: A Engberg (Sweden)
Prof. A Lindén Hirschberg (Sweden) Androgen insufficiency in women - fact or fiction?
Development & Improvement track
Improved diagnostics and new tests
Chair: A Linko-Parvinen (Finland)
Assoc Prof. T Männistö (Finland) Hypothyroidism is increasing – is it true or overdiagnosis
Assoc Prof. S Wittfooth (Finland) Recent developments in troponin assays
10:00 Coffee & Exhibition 10:30 Proteomics for diagnosing disease
Chair: L Tjernberg (Sweden)
CAR-T and CAR-NK Cell Therapy
Chair: C Gran (Sweden)
Assoc Prof E Alici (Sweden)
What clinical chemists should know about the interpretation of blood tests in transgender individuals
Chair: U Tietge (Sweden)
Prof. M den Heijer (Netherlands)
11:00 Break Aula Medica 11:15 Plenary session on Neurodegenerative disease: Fluid biomarkers for Alzheimer’s – finding the place of blood and CSF tests at the memory clinic and in the clinical chemistry lab
Chair: L Tjernberg (Sweden)
Prof. K Blennow (Sweden)
12:00 12:00-13:45 Lunch & Exhibition Aula Medica 12:30 Company session organised by Roche
Step into the future with cobas Mass Spec analyzer, i60113:00 12:00-13:45 Lunch & Exhibition Aula Medica Sune Bergström Hall Ulf von Euler Hall Blood biomarkers - A new era for diagnosing Alzheimer disease?
Chair: L Tjernberg (Sweden)
MD B Arslan (Sweden) Oral poster - Diagnostic performance of plasma p-tau 217 in the LUMIPULSE automated platform for the detection of amyloid pathology
Assoc Prof. S Schedin Weiss (Sweden) Glycans as novel biomarkers for Alzheimer disease
PhD S Gaunitz (Sweden) Glycomics at Clinical chemistry
Prof. L Jönsson (Sweden) Can we justify screening for Alzheimer disease?
Laboratory and cancer associated thrombosis (CAT) - where we are
Chair: J Antovic (Sweden)
Prof. A Falanga (Italy) CAT overview
Prof. J Odeberg (Sweden) Proteomics in CAT
PhD MD C Gran (Sweden) Extracellular Vesicles, Tissue Factor, and NETosis
Development & Improvement track
Oral Abstracts
Chairs: L Spendrup & M Johansson (Sweden)
J Ritvanen (Finland) Identification of heavy laboratory phlebotomy service users
PhD K Virtanen (Finland) New EQA Scheme for Improving Pipetting Quality
I Silvo (Finland) External quality assessment reveals lack of harmonization in the pneumatic tube systems and hemolysis index cutoffs
External quality assessment in laboratory medicine: what, how and why
Chairs: L Spendrup & M Johansson (Sweden)
Assoc Prof. L Björndahl (Sweden) How new standards are developed – the professions can be in charge
15:15 Coffee & Exhibition 15:45 Precision medicine: dream or reality?
Chair: P Parini (Sweden)
Assoc Prof. Å Wheelock (sweden)Network Medicine Approaches to Investigate Obstructive Lung Diseases: Multi-omics integrations – well worth the money spent?
PhD A O. Olsson (Sweden) Oral abstract - A practical approach to determine assay specific cut-offs for thyroid peroxidase antibodies
Session by BALM
Chair: U Tietge (Sweden)
PhD MD V Banys (Lithuania) & M Bieliauskas (Lithuania) Roadtrip towards harmonized reporting of laboratory results in Lithuania.
PhD A Tamm (Estonia) Digital transmission of laboratory data in Estonia.
E Kazušs (Latvia)The current progress in Latvia e-health system in laboratory medicine
Development & Improvement track
External quality assessment in laboratory medicine: what, how and why
Session in swedish
Chairs: L Spendrup & M Johansson (Sweden)
BSc Å Claesson (Sweden) The significance of accreditation for the laboratory
MSc M Dajaku (Sweden) Differences between ISO 15189:2012 and ISO 15189:2022
17:15 End of program -
Friday 20 September
Aula Medica Sune Bergström Hall Ulf von Euler Hall Education session
Unlocking the secrets of life through the power of data and bioinformaticsAssoc prof P Chen (Sweden)
Educational session - Analytical interference in Clinical chemistry
Educational session
Coagulation assays - an overview
08:15 Break 08:30 Development & Improvement track
The future of laboratories: trends, challenges and opportunities
Chair: G Dahlfors (Sweden)
PhD B Schadenberg (Holland) Robots in the Laboratory: From Stationary Machines to Mobile Workers
Biomed lab scientist L Nyman (Sweden) Implementing and working with collaborative robots in the Laboratory, benefits, and challenges
Session by Svensk Förening för Klinisk Kemi -
Using labs wisely – laboratory medicine in an era of choosing wisely.
Chair: J Skogö (Sweden)
Prof. K Stordal (Norway) Choosing Wisely - #More is not always better
MD K Bengtsson Linde (Sweden) Testing wisely to the right tree in the wood - how the Emergency department use laboratory testing in clinical decisionmaking
Development & Improvement track
Career and competence in laboratory medicine: challenges, trends and best practices
Session in Swedish
Chair: M Shafaati Lambert (Sweden)
BSc N Hourani Soutari (Sweden) -Integrerad forskning och kliniskt arbete
MSc H Stenling (Sweden) - Norrtäljeprojektet
Biomed lab scientist A Collberg (Sweden) - Runda Bordet
BSc M Kjellén & BSc J Borrman (Sweden) - Proteinelektroforesbedömning av biomedicinska analytiker
10:00 Coffee & Exhibition Aula Medica 10:30 The NFKK Young Researcher Award
Prof. MD LM Rasmussen (Denmark)
The three awarded will present their scientific work
PhD MD E L List (Denmark) - Accuracy of Diagnosing Heparin-Induced Thrombocytopenia
MSc S Salonen (Finland) - Highly sensitive immunoassay for long forms of cardiac
troponin T using upconversion luminescenceAssoc Prof L Steffensen (Denmark) - The landscape of somatic mutations in human atherosclerotic
plaques reveals the presence of large clonal cell populations12:00 Lunch Break 12:30 Plenary session by the Nordic Federation of Clinical Chemistry - Clinical metabolomics, a new era for laboratory medicine
Chairs: YT Bliksrub (Norway) and P Bjellerup (Sweden)
PhD Msc K Elgstøen (Norway) Global metabolomics, why and how
Prof. RMA Heeren (Netherlands) - Imaging Mass Spektrometry
PhD MD YT Bliksrud (Norway) Interpretation challenges, the need for the medical doctor in the laboratory
13:30-14:00 Closing ceremony with presentation of NFKK young researcher award and welcome to NCCC2026 Århus, Denmark 14:00 End of the Conference